Brain high-throughput multi-omics data reveal molecular heterogeneity in Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 187 of the 187 references it cites were found in a registry or an index.
Abstract
Unbiased data-driven omic approaches are revealing the molecular heterogeneity of Alzheimer disease. Here, we used machine learning approaches to integrate high-throughput transcriptomic, proteomic, metabolomic, and lipidomic profiles with clinical and neuropathological data from multiple human AD cohorts. We discovered 4 unique multimodal molecular profiles, one of them showing signs of poor cognitive function, a faster pace of disease progression, shorter survival with the disease, severe neurodegeneration and astrogliosis, and reduced levels of metabolomic profiles. We found this molecular profile to be present in multiple affected cortical regions associated with higher Braak tau scores and significant dysregulation of synapse-related genes, endocytosis, phagosome, and mTOR signaling pathways altered in AD early and late stages. AD cross-omics data integration with transcriptomic data from an SNCA mouse model revealed an overlapping signature. Furthermore, we leveraged single-nuclei RNA-seq data to identify distinct cell-types that most likely mediate molecular profiles. Lastly, we identified that the multimodal clusters uncovered cerebrospinal fluid biomarkers poised to monitor AD progression and possibly cognition. Our cross-omics analyses provide novel critical molecular insights into AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Fig 4 The parietal cortex of participants with worse cognitive function exhibited remarkable molecular dysregulation. (A) Bar plots showing the significant genes detected in each cluster compared to the control. Yellow represents the total number of genes, green represents the cluster-specific genes, and purple depicts the number of genes missed with an unclustered approach (all AD cases vs. control). (B) Same as panel “A” but for proteins. (C) Same as panel “A” but for metabolites. (D) Race track plot showing the percentage of significant features for each cluster compared to other clusters for the 3 omics. (E) Venn diagrams showing the overlap between significant genes in Knight-C4 and synaptic genes (“synaptosome”) from Fei and colleagues [46]. (F) Same as “E” but overlaps with SynGO dataset [47]. The significance of overlap was computed using Fisher’s exact test. (G) Top 20 KEGG pathways associated with Knight-C4. (H) Top 20 GO biological process pathways associated with Knight-C4. The data underlying panels A, B, and C can be found in S1 Data. AD, Alzheimer disease.](https://figures.cochat.ai/paper-figures/d7d9ccfe3a3549c0934558fd322d14fb/brain-high-throughput-multi-omics-data-reveal-molecular-heterogeneity-in-figure-4.jpg)





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Multimodal fusion may eventually support individualized signatures, but current evidence does not yet justify real-time clinical course correction or routine biomarker-guided antidepressant switching [405,406] (Figure 4).”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [405]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“To investigate these alterations, machine learning techniques have been employed to integrate transcriptomic and proteomic datasets, revealing widespread dysregulation within neurotrophic signaling networks in AD41,58.”
From Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: Progress, challenges, and future directions (2025) · cites this paper as [58]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This integrative analysis revealed molecular subtypes of AD that correlated with neuropathological severity and cognitive decline, implicating key biological pathways including endocytosis and cholesterol metabolism58.”
From Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: Progress, challenges, and future directions (2025) · cites this paper as [58]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“High-throughput transcriptomic and proteomic studies have delineated at least four molecular subtypes of AD, each characterized by distinct immune, metabolic, and inflammatory signatures that correlate with clinical trajectories58.”
From Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: Progress, challenges, and future directions (2025) · cites this paper as [58]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Single-cell multi-omics has further refined biomarker discovery by enabling cell-type and cell-state-specific resolution, though this granularity increases the computational burden and necessitates improved harmonization protocols58.”
From Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: Progress, challenges, and future directions (2025) · cites this paper as [58]
Experimental — accuracy not yet measured
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
WGCNA: an R package for weighted correlation network analysis
Langfelder, P., & Horvath, S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-559 · Cited by 27,252
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
FactoMineR : An R Package for Multivariate Analysis
Lê, S., Josse, J., & Husson, F. (2008) · Journal of Statistical Software · doi:10.18637/jss.v025.i01 · Cited by 11,603
Shrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,914
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Research works printed but not linked: 8
- CF Lippa, 1999, Antibodies to α-synuclein detect Lewy bodies in many Down’s syndrome brains with Alzheimer’s disease., Ann Neurol, 45, 353, 10.1002/1531-8249(199903)45:3<353::AID-ANA11>3.0.CO;2-4 · doi:10.1002/1531-8249(199903)45:3<353::aid-ana11>3.0.co;2-4
- S. Andrews, 2010, FastQC: a quality control tool for high throughput sequence data., Babraham Bioinformatics, Babraham Institute, Cambridge, United Kingdom
- Picard Toolkit., 2019, Broad Institute, GitHub Repository.
- S Lê, 2008, FactoMineR: an R package for multivariate analysis, J Stat Softw, 25, 1
- T Hastie, 2018, impute: impute: Imputation for microarray data., R package version.
- Q Mo, 2013, iClusterPlus: integrative clustering of multiple genomic data sets
- T. Therneau, 2020, A Package for Survival Analysis in R., R package version 3.2–3
- A. Eklund, 2017, surviplot: Draw Survival Curves with Number-at-Risk., R package version 1.1.1
Cited by
Ren, F., Wei, J., Chen, Q., Hu, M., Yu, L., Mi, J., Zhou, X., Qin, D., Wu, J., & Wu, A. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.07.030 · Cited by 97
Hein, Z. M., Karikalan, B., Gopalakrishna, P. K., Dhevi, K., Alkatiri, A., Hussan, F., Mohd Moklas, M. A., Jagadeesan, S., Che Ramli, M. D., Che Mohd Nassir, C. M. N., et al. (2026) · Molecular Neurobiology · doi:10.1007/s12035-025-05602-0 · Cited by 43
The mTOR pathway: a common link between Alzheimer's disease and Down Syndrome
Wohlfert, A. J., Phares, J., & Granholm, A.-C. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13206183 · Cited by 6
“A multi-omics study reported distinct molecular profiles in AD cases associated with decreased cognitive function, early onset/death, and dysregulated neuronal/synaptic pathways [113].”
BackgroundSchneegans, E., Fancy, N., Thomas, M., Adair, E., Willumsen, N., Papageorgopoulou, M., Chau, V., Cheung, T. K. D., Muirhead, R. C. J., Whitwell, H., et al. (2024) · doi:10.1101/2024.08.27.24312641 · Cited by 2
Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery
Tanaka, M. (2026) · Biomedicines · doi:10.3390/biomedicines14061265
Metadata
- Authors
- Eteleeb, A. M., Novotny, B. C., Tarraga, C. S., Sohn, C., Dhungel, E., Brase, L., Nallapu, A., Buss, J., Farias, F., Bergmann, K., Bradley, J., Norton, J., Gentsch, J., Wang, F., Davis, A. A., Morris, J. C., Karch, C. M., Perrin, R. J., Benitez, B. A., & Harari, O.
- Affiliations
- Washington University in St. Louis (US)
- University of North Carolina at Charlotte (US)
- Corresponding author
- Eteleeb, Abdallah M.
- Novotny, Brenna C.
- Sohn, Christopher
- Dhungel, Eliza
- Brase, Logan
- Nallapu, Aasritha
- Buss, Jared
- Farias, Fabiana
- Bergmann, Kristy
- Bradley, Joseph
- Norton, Joanne
- Gentsch, Jen
- Wang, Fengxian
- Davis, Albert A.
- Morris, John C.
- Karch, Celeste M.
- Perrin, Richard J.
- Harari, Oscar
- ORCID
- Venue
- PLOS Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2024-04-30
- Volume
- 22
- Issue
- 4
- Pages
- e3002607
- ISSN
- 1544-9173 (ISSN-L)
- 1545-7885
- PMC
- PMC11086901
- OpenAlex
- W4396506788
- Cited by
- 64
- References
- 187
- Citations by year
- 2026: 37 · 2025: 24 · 2024: 3
- FWCI
- 18.07
- Type
- journal article
- Language
- en
- Update notices
- new_version (2024-05-10)
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Institute on Aging (P30AG066444, P01AG003991, P01AG026276, R01AG057777, R01AG074012, U01AG072464, K01AG046374, R56AG067764, K25AG083057)
- National Institute of Neurological Disorders and Stroke (R01NS118146, R21NS127211)
- Chan Zuckerberg Initiative
- Beth Israel Deaconess Medical Center (2023 Translational Hub Spark Grant Award)
- Archer Foundation
- Knight Alzheimer Disease Research Center (P30 AG066444)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, molecular heterogeneity, transcriptomics, proteomics, metabolomics, lipidomics, astrocyte activation, synapse-related genes, mTOR signaling, endocytosis, phagosome, single-nucleus RNA sequencing, cell types, cerebrospinal fluid biomarkers, disease progression, cognitive decline, survival
- MeSH terms
- Machine Learning, Multiomics, Aged, Alzheimer Disease, Animals, Brain, Disease Models, Animal, Female, Humans, Male, Biomarkers, Disease Progression, Proteomics, Mice, Metabolomics, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.